Applications are now being accepted for the 2023 AIM-HI’s Women’s Venture Competition! Cash prizes will be awarded to the top 3 finalists, and the winning startup will receive up to US$1 million in investment, subject to due diligence and negotiations. Learn more.
The life sciences industry suffers from a lack of gender diversity. Women entrepreneurs are being overlooked for raising seed-stage money when launching a new company. According to the Association for Women in Science, less than 15% of angel funding and only 2% of venture capital is directed to companies started or led by women.
To address this critical need, AFCR worked with our strategic partners, the National Foundation for Cancer Research and AIM-HI Accelerator Fund (AIM-HI) to launch the AIM-HI Women’s Venture Competition, a first-of-its-kind initiative designed to highlight, energize and fund promising cancer treatment technology companies led by female scientist-entrepreneurs.
The Competition is to support women-led life-saving start-ups through venture philanthropy partnerships and provide these companies with valuable access to key opinion leaders. The combination of funding, insightful feedback from life sciences industry figures, increased visibility and credibility, and the opportunity to tap into so extensive a global network is highly unique and impactful.
